Total Payments
$1,185
2024 Payments
$70.92
Companies
19
Transactions
71
Medicare Patients
21,440
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$1,185 (99.9%)
Education$0.79 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,185 | 70 | 99.9% |
| Education | $0.79 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $347.30 | 24 | $0 (2024) |
| Astellas Pharma US Inc | $116.39 | 7 | $0 (2023) |
| Covidien LP | $96.50 | 2 | $0 (2019) |
| Lilly USA, LLC | $94.27 | 7 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $57.94 | 4 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $55.13 | 3 | $0 (2022) |
| Medtronic Vascular, Inc. | $52.74 | 1 | $0 (2017) |
| Sunovion Pharmaceuticals Inc. | $52.70 | 3 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $45.81 | 3 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $42.71 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $70.92 | 4 | ABBVIE INC. ($40.10) |
| 2023 | $196.77 | 12 | AbbVie Inc. ($58.48) |
| 2022 | $302.85 | 23 | ABBVIE INC. ($208.71) |
| 2021 | $111.67 | 7 | AstraZeneca Pharmaceuticals LP ($42.65) |
| 2020 | $40.16 | 3 | Allergan, Inc. ($14.50) |
| 2019 | $222.20 | 10 | Covidien LP ($96.50) |
| 2018 | $90.47 | 6 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($31.88) |
| 2017 | $150.44 | 6 | Medtronic Vascular, Inc. ($52.74) |
All Payment Transactions
71 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Diabetes | ||||||
| 08/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: NEUROSCIENCE | ||||||
| 05/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: NEUROSCIENCE | ||||||
| 01/08/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: HIV | ||||||
| 11/14/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Diabetes | ||||||
| 11/09/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Diabetes | ||||||
| 11/03/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Obesity | ||||||
| 09/27/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: NEUROSCIENCE | ||||||
| 09/21/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/26/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Biological | ||||||
| 06/15/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Diabetes | ||||||
| 06/07/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: VACCINES | ||||||
| 03/14/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Urology | ||||||
| 03/07/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: NEUROSCIENCE | ||||||
| 01/13/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Education | In-kind items and services | $0.79 | General |
| Category: UROLOGY | ||||||
| 11/22/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.82 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.72 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.34 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: NEUROSCIENCE | ||||||
| 08/11/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.13 | General |
| Category: NEUROSCIENCE | ||||||
| 07/21/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: NEUROSCIENCE | ||||||
| 06/02/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $8.67 | General |
| Category: NEUROSCIENCE | ||||||
| 06/02/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $1.47 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 65 | 4,999 | 19,714 | $1.3M | $255,949 |
| 2022 | 70 | 5,264 | 23,713 | $1.4M | $278,375 |
| 2021 | 71 | 5,294 | 29,184 | $1.3M | $271,684 |
| 2020 | 74 | 5,883 | 34,922 | $1.5M | $277,830 |
Total Patients
21,440
Total Services
107,533
Medicare Billing
$1.1M
Procedure Codes
280
All Medicare Procedures & Services
280 procedure records from CMS Medicare Utilization — Page 1 of 12
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 498 | 921 | $145,015 | $69,757 | 48.1% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 126 | 136 | $192,775 | $20,964 | 10.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 247 | 332 | $35,730 | $17,504 | 49.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 51 | 65 | $42,900 | $13,156 | 30.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 169 | 172 | $16,950 | $12,194 | 71.9% |
| 70553 | Mri scan of brain before and after contrast | Office | 2023 | 72 | 76 | $144,400 | $10,948 | 7.6% |
| 74183 | Mri scan of abdomen before and after contrast | Office | 2023 | 51 | 53 | $100,700 | $8,723 | 8.7% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 47 | 47 | $75,200 | $8,007 | 10.6% |
| 72158 | Mri scan of lower spinal canal before and after contrast | Office | 2023 | 51 | 51 | $96,900 | $7,617 | 7.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 487 | 773 | $11,595 | $6,418 | 55.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 40 | 42 | $19,740 | $5,981 | 30.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 21 | 22 | $9,060 | $5,638 | 62.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 395 | 435 | $30,450 | $5,589 | 18.4% |
| 71260 | Ct scan of chest with contrast | Office | 2023 | 89 | 101 | $63,290 | $5,493 | 8.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 171 | 174 | $6,960 | $4,995 | 71.8% |
| 78306 | Nuclear medicine study of bone and/or joint whole body | Office | 2023 | 28 | 29 | $16,665 | $4,738 | 28.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 396 | 426 | $25,560 | $4,347 | 17.0% |
| 78227 | Nuclear medicine study of liver and bile duct system with use of drugs | Office | 2023 | 14 | 14 | $17,750 | $3,617 | 20.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 138 | 197 | $13,790 | $3,215 | 23.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 167 | 293 | $13,185 | $2,713 | 20.6% |
| 72197 | Mri scan of pelvis before and after contrast | Office | 2023 | 17 | 17 | $32,130 | $2,577 | 8.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 20 | 20 | $3,390 | $2,449 | 72.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 88 | 168 | $5,880 | $2,375 | 40.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 267 | 295 | $11,800 | $2,217 | 18.8% |
| 93701 | Measurement of heart blood flow and respiration | Office | 2023 | 53 | 98 | $12,250 | $1,606 | 13.1% |
About Dr. Joseph Baker, MD
Dr. Joseph Baker, MD is a Internal Medicine healthcare provider based in Rome, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396805644.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Baker, MD has received a total of $1,185 in payments from pharmaceutical and medical device companies, with $70.92 received in 2024. These payments were reported across 71 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,185).
As a Medicare-enrolled provider, Baker has provided services to 21,440 Medicare beneficiaries, totaling 107,533 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 280 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Rome, GA
- Active Since 12/09/2006
- Last Updated 03/23/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1396805644
Products in Payments
- VRAYLAR (Drug) $320.68
- Situate (Device) $96.50
- XIFAXAN (Drug) $59.59
- QULIPTA (Drug) $57.40
- Myrbetriq (Drug) $54.94
- Arctic Front (Device) $52.74
- LONHALA MAGNAIR (Drug) $52.70
- TRULICITY (Drug) $51.28
- MYRBETRIQ (Drug) $43.68
- MOUNJARO (Drug) $42.99
- BREZTRI (Drug) $42.65
- TRADJENTA (Drug) $35.57
- ADVAIR (Drug) $30.27
- XARELTO (Drug) $28.31
- Rybelsus (Drug) $20.95
- ENTRESTO (Drug) $20.33
- JARDIANCE (Drug) $19.56
- Wegovy (Drug) $19.08
- Veozah (Drug) $17.77
- RUKOBIA (Drug) $17.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Rome
Dr. Kunal Patel, M.d, M.D
Internal Medicine — Payments: $15,383
Internal Medicine $15,383
Raul Gonzalez, Md, MD
Internal Medicine — Payments: $12,656
Internal Medicine $12,656
Mourad Nessim, Md, MD
Internal Medicine — Payments: $10,097
Internal Medicine $10,097
Dr. Joseph Herren, Md, MD
Internal Medicine — Payments: $8,646
Internal Medicine $8,646
George Hotz, M.d, M.D
Internal Medicine — Payments: $6,225
Internal Medicine $6,225
Anandita Arora, Md, MD
Internal Medicine — Payments: $5,451
Internal Medicine $5,451